Veterinary Antibiotics Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Veterinary Antibiotics Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Antibiotics are used in livestock production to treat diseases in animals, to control infection of disease among healthy animals, to prevent disease in animals, and to increase animal productivity. Antibiotics keep poultry and livestock healthy, thereby reducing the chance of bacterial transmission from animals to humans. Majority of antibiotics drugs approved for use in food-producing animals through their feed or water are available over-the-counter.
Market Dynamics
Increasing demand for animal protein and growing demand for food production from animal source is leading driver for use of antibiotics in animal agriculture. Several countries across the world produce meat and aquaculture products. According to Organization for Economic Co-Operation and Development (OECD), an average U.S. adult consumed 198 pounds of meat in 2014. According to the WHO 2015 report, South East Asia region (SEAR) has developed intensive farming systems, leading to the rising consumption of fertilisers, antibiotics, and pesticides.
However, over-use and misuse of antibiotics in animals and humans is rising threat of antibiotic resistance. Therefore, governments across the globe are banning or limiting use of antibiotics in animal production and growth. For instance, in November 2021, European Union (EU) approved restrictions on Veterinary Antibiotics. The new legislation, which is expected to become law by 2022, bans use of antibiotics for animals, which are important for human medicine and prohibits use of any antimicrobials in livestock without a prescription from a veterinary doctor. In 2016, the United Nations General Assembly (UNGA) brought together the global community in declaring antimicrobial resistance (AMR) as a major concern and a global commitment to fight an issue through multi-pronged approaches.
Key features of the study:
This report provides in-depth analysis of the veterinary antibiotics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global veterinary antibiotics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi, Vetoquinol S.A., Virbac, and Zoetis, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global veterinary antibiotics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for veterinary antibiotics market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Veterinary Antibiotics Market, By Product Type:
Anti-parasitic
Anti-bacterial
Non-steroidal anti-inflammatory drug
Others
Global Veterinary Antibiotics Market, By End Use:
Dairy Farm
Poultry Farm
Others
Global Veterinary Antibiotics Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Anti-parasitic
Anti-bacterial
Non-steroidal anti-inflammatory drug
Others
By End Use:
Dairy Farm
Poultry Farm
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Anti-parasitic
Anti-bacterial
Non-steroidal anti-inflammatory drug
Others
By End Use:
Dairy Farm
Poultry Farm
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Anti-parasitic
Anti-bacterial
Non-steroidal anti-inflammatory drug
Others
By End Use:
Dairy Farm
Poultry Farm
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Anti-parasitic
Anti-bacterial
Non-steroidal anti-inflammatory drug
Others
By End Use:
Dairy Farm
Poultry Farm
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Anti-parasitic
Anti-bacterial
Non-steroidal anti-inflammatory drug
Others
By End Use:
Dairy Farm
Poultry Farm
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Product Type:
Anti-parasitic
Anti-bacterial
Non-steroidal anti-inflammatory drug
Others
By End Use:
Dairy Farm
Poultry Farm
Others
Company Profiles
Bayer AG*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Boehringer Ingelheim GmbH
Ceva Sante Animale S.A.
Crystal Pharma
Dechra Pharmaceuticals PLC
Huvepharma AD
Eli Lilly Company
Merck & Co., Inc.
Sanofi S.A.
Vetoquinol S.A.
Virbac
Zoetis, Inc.
“*” marked represents similar segmentation in other categories in the respective section.